does semaglutide make you break out Study: No Link Seen Between GLP-1 Agonists and Acne in Women Top 5 Common Semaglutide Side

Retatrutide , a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, is in clinical development

Basically a study looked at 100 drugs & found that 90% of them were fully potent 15 years after their expiration date, though that may vary by drug, and perhaps liquid forms are a bit more vulnerable (perhaps)

Human Factors of Dosing Confusion and Syringe Errors The step up from a pre-filled, dose-calibrated manufacturers pen to a multidose vial and insulin syringe is huge, and therefore more prone to error

Lubos E, et al

So we need to know, if a health benefit is found did it happen before any weight loss occurs

If you already know what you are dealing with, use the selector below to jump directly to your section